(Q46656102)

English

Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage

scientific article published in February 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

blood–brain barrier

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

author name string

Su GC

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

Arendash GW

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

Kalaria RN

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

Bjugstad KB

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

818

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

105-117

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Effect of tumor necrosis factor-alpha on the permeability of bovine brain microvessel endothelial cell monolayers.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Scavenging of Alzheimer's amyloid beta-protein by microglia in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Patterns of gliosis in Alzheimer's disease and aging cerebrum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Brain microvascular changes in Alzheimer's disease and other dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Platelets are the primary source of amyloid beta-peptide in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Perivascular astrocytes within Alzheimer's disease plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Alzheimer amyloid beta-peptides exhibit ionophore-like properties in human erythrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

The alveolar macrophage

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Complement C1q and C3 mRNA expression in the frontal cortex of Alzheimer's patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Interleukin-1 modulates protein tyrosine phosphatase activity and permeability of brain endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Microglial release of nitric oxide by the synergistic action of beta-amyloid and IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Amyloid beta-protein (A beta) accumulation in the leptomeninges during aging and in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Differential degeneration of the cerebral microvasculature in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Activation of macrophages by Alzheimer beta amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Cerebral amyloid angiopathy and astrocytic gliosis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Activation of the classical complement pathway in brain tissue of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Differences between vascular and plaque core amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

beta-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Cerebrovascular endothelial dysfunction mediated by beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Cerebral amyloid angiopathy. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

In vitro production of beta-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Blood-brain barrier transport of circulating Alzheimer's amyloid beta

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(98)01143-3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46656102&oldid=2124977527"